newsfilter
← Latest News
FDA Approved Drugs·

Approval of Zynyz, Bla #761334

Approval Date: 05/18/2026; Drug Name: Zynyz, Bla #761334; Active Ingredients: RETIFANLIMAB-DLWR; Company: Incyte Corp; Submission Status: Approval; Application Number: 761334

Company
INCYTE CORP
Keywords
INCYTE CORP